Shi Zhuo

Title: The Innovations of Shi Zhuo

Introduction

Shi Zhuo is a prominent inventor based in Chengdu, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative antibody therapies. With a total of four patents to his name, his work has the potential to impact cancer treatment and other medical applications.

Latest Patents

Shi Zhuo's latest patents include groundbreaking inventions such as bispecific tetravalent antibodies and methods of making and using them. This bispecific tetravalent antibody comprises an IgG with a pair of heavy chains and a pair of light chains, along with two scFv components connected to either the C or N terminals of the heavy or light chains. This innovative antibody may exhibit binding specificity for two different members of the EGFR family. Another notable patent is the non-natural amatoxin-type antibody conjugate. This conjugate, similar to natural amatoxin, is linked to a biopharmaceutically acceptable salt with a target biomolecule, ensuring stability in blood plasma and effectively killing tumor cells.

Career Highlights

Throughout his career, Shi Zhuo has worked with several notable companies, including Systimmune, Inc. and Sichuan Baili Pharmaceutical Co. Ltd. His experience in these organizations has allowed him to refine his skills and contribute to the advancement of biopharmaceutical technologies.

Collaborations

Shi Zhuo has collaborated with talented individuals in his field, including Yi Zhu and Lan Chen, who is a woman. These collaborations have fostered a creative environment that encourages innovation and the development of new ideas.

Conclusion

Shi Zhuo's contributions to the field of biopharmaceuticals through his innovative patents and collaborations highlight his importance as an inventor. His work continues to pave the way for advancements in medical treatments and therapies.